The health, safety and wellbeing of our employees, clinical trial participants and customers remains our highest priority given the ongoing geopolitical situation in Ukraine. We are closely monitoring and following the developments, and regularly updating our customers and teams through ongoing communications.



Corporate Updates Corporate Updates

During this challenging time, we are committed to frequent communication about the steps we are taking in response to the crisis in Ukraine, with the goal of ensuring that the vital work of delivering new therapies to patients continues.




Powered by GlobalLink OneLink Software